Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP in Norway: a Pragmatic Randomised Controlled Trial

NCT04660084 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT04660084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04660084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP in Norway: a Pragmatic Randomised Controlled Trial
Lead sponsor
Haukeland University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 25, 2020
Completion date
June 21, 2022
Enrollment
374 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia